What Happened?
Brisbane, CA-based Unity Biotechnology Resigned Susan Lundeen as Chief Human Resources Officer
About the Company
Unity Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY`s initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases.
About the Person
Susan Lundeen is Chief People Officer at Allogene. Previously, Susan held various senior HR leadership roles in the industry.
Info Source
News
Short Profile